BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 94057)

  • 1. Treatment of locally advanced squamous cell carcinoma of the head and neck with concurrent bleomycin and external beam radiation therapy.
    Seagren SL; Byfield JE; Nahum AM; Bone RC
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1531-5. PubMed ID: 94057
    [No Abstract]   [Full Text] [Related]  

  • 2. Low dose rate irradiation of advanced head and neck cancers: present status.
    Pierquin BM; Mueller WK; Baillet F
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):565-72. PubMed ID: 711529
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of squamous cell carcinomas of the head and neck region with cobalt and bleomycin.
    Kapstad B
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):91-4. PubMed ID: 75879
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined preoperative treatment with cobalt and bleomycin in patients with head and neck carcinoma--a controlled clinical study.
    Kapstad B; Bang G; Rennaes S; Dahler A
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):85-9. PubMed ID: 75878
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined bleomycin and irradiation.
    Rygård J; Hansen HS
    Can J Otolaryngol; 1975; 4(2):209-12. PubMed ID: 49219
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of squamous cell carcinomas in head and neck with bleomycin and with combined bleomycin and x-rays.
    Berdal P; Ekroll T; Iversen OH; Weyde R
    Acta Otolaryngol; 1973 Apr; 75(4):318-20. PubMed ID: 4122084
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined bleomycin treatment and radiation therapy in squamous cell carcinoma of the head and neck region.
    Parvinen LM; Parvinen M; Nordman E; Kortekangas AE
    Acta Radiol Oncol; 1985; 24(6):487-9. PubMed ID: 2420153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preradiation peplomycin for advanced squamous cell carcinomas.
    Azhar T; Singh P
    Med J Malaysia; 1988 Mar; 43(1):40-3. PubMed ID: 2468988
    [No Abstract]   [Full Text] [Related]  

  • 9. Bleomycin: its utilization in the treatment of head and neck cancer.
    Bone RC; Byfield JE; Feren AP; Seagren SL
    Laryngoscope; 1979 Feb; 89(2 Pt 1):224-33. PubMed ID: 85232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bleomycin for epidermoid carcinoma of head and neck.
    Taketa C; Shimosato Y; Nagano A; Washizu K; Matsuura S; Ono I; Ebihara S
    Jpn J Clin Oncol; 2010 Sep; 40(9):e41-53. PubMed ID: 20736214
    [No Abstract]   [Full Text] [Related]  

  • 11. The place of bleomycin in the treatment of highly differentiated squamous cell cancer either alone or in combination with irradiation.
    Rygård J; Hansen HS
    Prog Biochem Pharmacol; 1976; 11():205-18. PubMed ID: 63966
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of Bleomycin in tumor pateints].
    Rieche K; Matthias M
    Arch Geschwulstforsch; 1973; 41(3):232-40. PubMed ID: 4126058
    [No Abstract]   [Full Text] [Related]  

  • 13. A multidisciplinary therapeutic approach for advanced previously untreated epidermoid cancer of the head and neck: preliminary report.
    Al-Sarraf M; Amer MH; Vaishampayan G; Loh J; Weaver A
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1421-3. PubMed ID: 93595
    [No Abstract]   [Full Text] [Related]  

  • 14. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cobalt and bleomycin against carcinomas of head and neck. A controlled clinical study.
    Kapstad B
    Acta Otolaryngol Suppl; 1979; 360():171-3. PubMed ID: 88161
    [No Abstract]   [Full Text] [Related]  

  • 16. Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: an active drug combination with major nonhematologic toxicity.
    Ihde DC; Cohen MH; Bunn PA; Bernath AM; Broder LE; Minna JD
    Cancer Treat Rep; 1978 Jan; 62(1):155-7. PubMed ID: 75065
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer.
    Hartley A; Sanghera P; Kazi W; Mehanna H; McConkey C; Glaholm J; Fowler J
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):29-33. PubMed ID: 20829006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced head and neck carcinoma with synchronous irradiation and methotrexate.
    Pointon RC; Askill CS; Hunter RD; Wilkinson PM
    Cancer Treat Rep; 1981; 65 Suppl 1():145-8. PubMed ID: 7326659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
    Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma prostaglandins in mucositis due to radiotherapy and chemotherapy for head and neck cancer.
    Tanner NS; Stamford IF; Bennett A
    Br J Cancer; 1981 Jun; 43(6):767-71. PubMed ID: 7248158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.